Collegium Pharmaceutical (COLL) Other Non-Current Liabilities (2014 - 2025)

Collegium Pharmaceutical (COLL) recorded quarterly Other Non-Current Liabilities of $19000.0 in Q3 2025, down 50.0% quarter-over-quarter from $38000.0 in Q2 2025, and down 99.54% on a YoY basis from $4.1 million in Q3 2024.

Collegium Pharmaceutical (COLL) Other Non-Current Liabilities (2014 - 2025) Analysis & Trends

Collegium Pharmaceutical's Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $19000.0 for Q3 2025.

  • In Q3 2025, Other Non-Current Liabilities fell 99.54% year-over-year to $19000.0; the TTM figure through Sep 2025 stood at $19000.0 (down 99.54% YoY), while the FY2024 annual figure was $1.2 million, changed N/A from the prior year.
  • Other Non-Current Liabilities was $19000.0 for Q3 2025 at Collegium Pharmaceutical, down from $38000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $4.1 million in Q3 2024 to a low of $19000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Collegium Pharmaceutical 1.10 Bn 813.71 Mn 117.25 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 19,000.00
Jun 30, 2025 38,000.00
Mar 31, 2025 396,000.00
Dec 31, 2024 1.18 Mn
Sep 30, 2024 4.10 Mn
Dec 31, 2018 676,000.00
Sep 30, 2018 284.83 Mn
Jun 30, 2018 314.45 Mn
Mar 31, 2018 343.73 Mn
Sep 30, 2017 8,000.00
Jun 30, 2017 17,000.00
Mar 31, 2017 25,000.00
Dec 31, 2016 34,000.00
Sep 30, 2016 42,000.00
Jun 30, 2016 51,000.00
Mar 31, 2016 59,000.00
Dec 31, 2015 68,000.00
Sep 30, 2015 76,000.00
Jun 30, 2015 85,000.00
Mar 31, 2015 93,000.00